| Rank |
Status |
Study |
| 1 |
Unknown †
|
Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
| Conditions: |
Muscular Atrophy; Sprains; Tendonitis |
| Interventions: |
Drug: Ibuprofen; Drug: Profenid |
| Outcome Measures: |
Clinical study evaluating the efficacy and safety of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, Contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. "; Clinical study evaluating the tolerability of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, Contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. " |
|
| 2 |
Unknown †
|
Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma
| Conditions: |
Blunt Chest Trauma; Acute Respiratory Distress Syndrome |
| Interventions: |
Drug: standard care treatment; Drug: Celecoxib; Drug: Rosuvastatin; Drug: Combined therapy |
| Outcome Measure: |
1. Signs of ALI, i.e., pneumonia, adult respiratory distress syndrome [ARDS] |
|
| 3 |
Unknown †
|
To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
| Conditions: |
Contusions; Sprains; Trauma; Muscle Injury; Myalgia; Myofascial Pain; Tendinitis |
| Interventions: |
Drug: Aliviador; Drug: Gelol |
| Outcome Measures: |
To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol.; To evaluate the tolerability use Aliviador compared to Gelol. |
|
| 4 |
Unknown †
|
Efficacy and Safety of Salonsip Compared to Sabiá Plaster
| Conditions: |
Contusions; Sprains; Myalgia; Pain; Tendonitis |
| Interventions: |
Drug: Salonsip plaster; Drug: Sabia plaster |
| Outcome Measures: |
Likert Scales and Visual Analogue Scales; Safety evaluation by adverse events relate. |
|
| 5 |
Unknown †
|
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
| Conditions: |
Traumatic Brain Injury; Subdural Hematoma; Cerebral Contusion; Head Injury; Cerebral Edema |
| Interventions: |
Drug: Induced, sustained hypernatremia using hypertonic saline; Drug: Standard of care (hypertonic saline and mannitol; serum sodium) |
| Outcome Measures: |
Primary Efficacy Objective; Primary Safety Objective; Short term neurological outcome |
|
| 6 |
Unknown †
|
Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols
| Conditions: |
Sprains and Strains; Contusions |
| Interventions: |
Drug: etoricoxib 90mg 14 days; Drug: etoricoxib 60mg daily for 14 days |
| Outcome Measures: |
Reduction of pain during active mobilization measured using a visual analogue scale VAS at day 8; Volumetric measurement of the ankle and foot; Pain during motion against resistance; Functional impairment and global assessment of efficacy by either patient and investigator; Tolerability will be assessed by the frequency of adverse experiences and global assessment of efficacy by either patient and investigator |
|
| 7 |
Unknown †
|
The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
| Condition: |
Traumatic Brain Injury |
| Interventions: |
Drug: D-cycloserine; Drug: placebo |
| Outcome Measures: |
A battery of neuropsychological tests at 3 and 6 months post-injury; Glasgow Outcome Score - Extended (GOS-E) |
|
| 8 |
Not yet recruiting
|
Great Saphenous Vein Electrocoagulation
| Conditions: |
Venous Disease; Varicose Veins |
| Interventions: |
Device: GSV Electrocoagulation; Device: GSV Radiofrequency |
| Outcome Measures: |
GSV occlusion; Pain VAS; Post operative bruising; Post operative sensory abnormality; Venous Clinical Severity Score (VCSS); Aberdeen Varicose Vein Questionnaire (AVVQ); Deep Venous Thrombosis (DVT); Clinical Etiology Anatomy Pathophysiology (CEAP) |
|
| 9 |
Not yet recruiting
|
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
| Condition: |
Postoperative Ecchymosis |
| Intervention: |
Drug: DDAVP |
| Outcome Measures: |
Reduction in Ecchymosis and Swelling; Patient Behavior Factors |
|
| 10 |
Recruiting
|
Attention Intervention Management
| Conditions: |
Traumatic Brain Injury (TBI); Attention Deficit Hyperactivity Disorder (ADHD); Head Injury; Brain Concussion; Head Injuries, Closed |
| Intervention: |
Behavioral: AIM |
| Outcome Measures: |
Parent Report Measures; Teacher Report Measures |
|
| 11 |
Recruiting
|
Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT)--RRTC
| Condition: |
Traumatic Brain Injury |
| Interventions: |
Behavioral: Internet-based Interacting Together Everyday: Recovery After Childhood TBI (I-InTERACT); Behavioral: Internet-based-Interacting Together Everyday, Recovery after Childhood TBI Express (I-InTERACT Express); Behavioral: Internet Resources Comparison (IRC) |
| Outcome Measures: |
Parent Report Measures; Neuropsychological Testing |
|
| 12 |
Recruiting
|
Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Teen Online Problem Solving Study
| Condition: |
Traumatic Brain Injury |
| Interventions: |
Behavioral: Teen Online Problem Solving (TOPS); Behavioral: Teen Online Problem Solving--Teen Only (TOPS-TO); Behavioral: Internet Resources Comparison (IRC) |
| Outcome Measures: |
Parent Report Measures; Teen Self-Report Measures; Neuropsychological Testing |
|
| 13 |
Recruiting
|
Clinical Study Comparing the Efficacy of Transbuccal Paracetamol 125 mg Versus Paracetamol Injection 1g in Slow Infusion IV in Patients With Acute Pain
| Condition: |
Acute Pain |
| Interventions: |
Drug: paracetamol; Drug: Placebo |
| Outcome Measure: |
Pain score measured by visual analogue scale |
|
| 14 |
Unknown †
|
Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift
| Condition: |
Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant |
| Intervention: |
Drug: Fibrin Sealant (Artiss) |
| Outcome Measures: |
Comparison of ecchymosis and edema; Resolution of ecchymosis and edema, incidence of hematoma/seroma |
|
| 15 |
Recruiting
|
A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures
| Condition: |
Ecchymosis and Erythema Commonly Associated With Soft Tissue Filler Injections and Facial Ablative Laser Resurfacing Treatments. |
| Intervention: |
Dietary Supplement: Multizyme Cellular Vitality Cyruta Plus SHEP |
| Outcome Measures: |
Canfield Vectra Photography; Heatherton & Polivy State Self-Esteem (HPSS) Scale, (SkinReplica) at Day 30 as compared to baseline (ablative laser group only, Global Aesthetic Improvement Scale (GAIS, |
|
| 16 |
Recruiting
|
Prospective Observation of Wound Healing With Prevena Incision Management System
| Condition: |
Scarring |
| Intervention: |
Device: Prevena |
| Outcome Measure: |
Scarring |
|
| 17 |
Recruiting
|
Gene Therapy for Wiskott-Aldrich Syndrome
| Condition: |
Wiskott-Aldrich Syndrome |
| Intervention: |
Genetic: Autologous CD34 positive cells transduced with WAS encoding lentiviral vector. |
| Outcome Measures: |
Conditioning regimen-related safety; Safety of lentivirus gene transfer into HSC; Sustained engraftment of genetically corrected haematopoietic stem cells in peripheral blood and/or in bone marrow; Expression of vector-derived WASP; Improved T-cell functions; Antigen-specific responses to vaccination; Improved platelet count; Lack of immune response to transgene; Reduced frequency of severe infections; Reduced bruising and bleeding episodes; Reduced autoimmunity phenomena and eczema; Improved quality of life |
|
| 18 |
Not yet recruiting
|
Efficacy of Arnica D1 Ointment After Upper Blepharoplasty
| Conditions: |
Blepharoplasty; Upper Eyelid Blepharoplasty |
| Interventions: |
Drug: Arnica; Drug: Placebo ointment |
| Outcome Measures: |
Surgical outcome; amount of tissue swelling; redness; pain; postoperative recovery; patient satisfaction |
|
| 19 |
Recruiting
|
STOPAIN in the Treatment of a Single Migraine Attack
| Condition: |
Migraine |
| Intervention: |
Drug: STOPAIN topical gel |
| Outcome Measures: |
Efficacy of STOPAIN in the Acute Treatment of Migraine; evaluate the tolerability, safety, and sustained pain freedom of STOPAIN |
|
| 20 |
Not yet recruiting
|
Evaluation of Wound Drainage After Knee or Hip Arthroplasty
| Condition: |
Complications; Arthroplasty |
| Interventions: |
Drug: Rivaroxaban (Xarelto); Drug: Warfarin (Coumadin) |
| Outcome Measures: |
Number of days until a dry wound; Amount and character of wound drainage; Number of days in the hospital postoperatively.; Incidence of wound infection; Incidence of additional operations |
|
